Cuorips

Cuorips Forward P/E

The Forward P/E Ratio of Cuorips (4894.T) as of Oct 16, 2026 is -88.33. In the previous year, Forward P/E Ratio was -140.20 — a change of -36.99% (higher).

Forward P/E

-88.33

YoY

-36.99%

Last updated:

Forward P/E Ratio of Cuorips is 2026 -88.33 . Forward P/E Ratio of Cuorips was 2025 -140.20 . It decreases by -36.99% higher compared to the previous year.

The Cuorips Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2021
-293.45 JPY
Jan 1, 2022
-240.67 JPY
Jan 1, 2023
-199.82 JPY
Jan 1, 2024
-142.89 JPY
Jan 1, 2025
-140.20 JPY
Jan 1, 2026
-88.33 JPY
The Cuorips Forward P/E history
YEARForward P/EYoY
-88.33-36.99%
-140.20-1.89%
-142.89-28.49%
-199.82-16.97%
-240.67-17.98%
-293.45—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cuorips Stock analysis

What does Cuorips do? Cuorips Inc is a Japanese company operating in the Health Care sector, specifically within Biotechnology. Headquartered in Chuo-Ku, Tokyo, the company focuses on the development and commercialization of regenerative medical products, with a particular emphasis on human iPS cell-derived cardiomyocyte sheets. Cuorips also engages in a contract development and manufacturing organization (CDMO) business, utilizing its CLiC-1 facility, a commercial cell culture and processing center designed according to the company's original concept. The company has 46 full-time employees and completed its initial public offering (IPO) on June 27, 2023. Cuorips collaborates with universities, research institutions, and major pharmaceutical companies for in-house research and joint research initiatives. Its primary product, human iPS cell-derived cardiomyocyte sheets, is targeted at regenerative medical applications for the heart and other areas. The company's website is https://cuorips.co.jp/. Cuorips is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cuorips stock

Forward P/E Ratio of Cuorips is -88.33 in 2026.

Forward P/E Ratio of Cuorips changed from -140.20 to -88.33, representing a -36.99% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Cuorips since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Cuorips with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Cuorips

All Key Metrics — Cuorips